U.S. High Court Extends Response Deadline In Review Of 9th Circuit FCA Suit Ruling
WASHINGTON, D.C. — The U.S. Supreme Court on June 3 granted a 30-day extension for the qui tam plaintiff in a district court decision to respond to pharmaceutical companies’ petition seeking...To view the full article, register now.
Already a subscriber? Click here to view full article